Canada Life’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Canada Life’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-4,001	Closed	-$7K	–	2692
2015 Q2	$7K	Hold	4,001	–	–	﹤0.01%	2564
2015 Q1	$6K	Buy	4,001 +290	+8%	+$435	﹤0.01%	2479
2014 Q4	$6K	Hold	3,711	–	–	﹤0.01%	2472
2014 Q3	$8K	Buy	3,711 +410	+12%	+$884	﹤0.01%	2421
2014 Q2	$10K	Hold	3,301	–	–	﹤0.01%	2317
2014 Q1	$8K	Hold	3,301	–	–	﹤0.01%	2226
2013 Q4	$16K	Buy	+3,301	New	+$16K	﹤0.01%	2169

Other funds holding RXII

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Canada Life's RXII Position: Q3 2015 in Review

Canada Life sold out of GALENA BIOPHARMA INC COM (RXII) in Q3 2015, closing a stake of 4,001 shares — an estimated $7K sold.

Canada Life first reported a position in RXII in Q4 2013 and held it in 7 quarters. The position peaked at $16K in Q4 2013. 78 funds tracked by Wall St. Rank hold RXII as of Q3 2015.

Canada Life reported no remaining GALENA BIOPHARMA INC COM position as of Q3 2015 after selling out during the quarter.
Canada Life sold 4,001 GALENA BIOPHARMA INC COM shares in Q3 2015, an estimated $7K.
Canada Life first reported a position in GALENA BIOPHARMA INC COM in Q4 2013 and held it in 7 quarters.
Canada Life's GALENA BIOPHARMA INC COM position peaked at $16K in Q4 2013.
78 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q3 2015.

Based on Canada Life's 13F filing for Q3 2015, filed 10 Nov 2015.